| # | Drug | Count |
|---|---|---|
| 0 | AXICABTAGENE CILOLEUCEL | 115 |
| 1 | FLUDARABINE PHOSPHATE | 20 |
| 2 | CYCLOPHOSPHAMIDE | 17 |
| 3 | CYCLOPHOSPHAMIDE FOR INJECTION | 17 |
| 4 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 17 |
| 5 | ACETAMINOPHEN | 10 |
| 6 | VANCOMYCIN | 10 |
| 7 | VANCOMYCIN HYDROCHLORIDE | 10 |
| 8 | FLUCONAZOLE | 9 |
| 9 | LEVETIRACETAM | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AXICABTAGENE CILOLEUCEL | 115 | 0.0113 |
| 1 | PROPARACAINE HYDROCHLORIDE | 1 | 0.0019 |
| 2 | SILTUXIMAB | 1 | 0.0015 |
| 3 | I. V. FAT EMULSION | 1 | 0.0014 |
| 4 | VANCOMYCIN HYDROCHLORIDE | 10 | 0.0012 |
| 5 | FILGRASTIM-SNDZ | 3 | 0.0009 |
| 6 | SODIUM CITRATE | 1 | 0.0008 |
| 7 | CHLOROTHIAZIDE | 1 | 0.0008 |
| 8 | ISAVUCONAZONIUM SULFATE | 3 | 0.0008 |
| 9 | ANTI-FUNGAL MICONAZOLE ATHLETES FOOT SPRAY TALC FREE | 1 | 0.0007 |
| # | Drug class | Count |
|---|---|---|
| 0 | CD19-directed Chimeric Antigen Receptor [EPC] | 115 |
| 1 | Genetically-modified Autologous T Cells [EPC] | 115 |
| 2 | Alkylating Drug [EPC] | 17 |
| 3 | Azole Antifungal [EPC] | 11 |
| 4 | Glycopeptide Antibacterial [EPC] | 10 |
| 5 | Expectorant [EPC] | 9 |
| 6 | Osmotic Laxative [EPC] | 7 |
| 7 | Potassium Salt [EPC] | 7 |
| 8 | Benzodiazepine [EPC] | 6 |
| 9 | Interleukin-6 Receptor Antagonist [EPC] | 6 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD19-directed Chimeric Antigen Receptor [EPC] | 115 | 0.0113 |
| 1 | Interleukin-6 Antagonist [EPC] | 1 | 0.0015 |
| 2 | Neuraminidase Inhibitor [EPC] | 1 | 0.0004 |
| 3 | Lipid Emulsion [EPC] | 1 | 0.0004 |
| 4 | Vitamin K [EPC] | 3 | 0.0003 |
| 5 | Plasma Volume Expander [EPC] | 1 | 0.0003 |
| 6 | Calcitonin [EPC] | 1 | 0.0003 |
| 7 | Gadolinium-based Contrast Agent [EPC] | 1 | 0.0002 |
| 8 | Antimalarial [EPC] | 2 | 0.0002 |
| 9 | Antiprotozoal [EPC] | 2 | 0.0002 |